These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24571671)

  • 61. [Sickle-cell anemia and pain].
    de la Brière A
    Soins; 2012; (767):14-7. PubMed ID: 22916389
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nebulized fentanyl vs intravenous morphine for ED patients with acute limb pain: a randomized clinical trial.
    Farahmand S; Shiralizadeh S; Talebian MT; Bagheri-Hariri S; Arbab M; Basirghafouri H; Saeedi M; Sedaghat M; Mirzababai H
    Am J Emerg Med; 2014 Sep; 32(9):1011-5. PubMed ID: 25027194
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The presentation and management of the acute abdomen in the patient with sickle-cell anemia.
    Baumgartner F; Klein S
    Am Surg; 1989 Nov; 55(11):660-4. PubMed ID: 2817619
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Emergency department management of acute pain episodes in sickle cell disease.
    Tanabe P; Myers R; Zosel A; Brice J; Ansari AH; Evans J; Martinovich Z; Todd KH; Paice JA
    Acad Emerg Med; 2007 May; 14(5):419-25. PubMed ID: 17389246
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intravenous narcotic therapy for children with severe sickle cell pain crisis.
    Cole TB; Sprinkle RH; Smith SJ; Buchanan GR
    Am J Dis Child; 1986 Dec; 140(12):1255-9. PubMed ID: 3776942
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevalence of morphine use and time to initial analgesia in an Australian emergency department.
    Forero R; Mohsin M; McCarthy S; Young L; Ieraci S; Hillman K; Santiano N; Bauman A; Phung H
    Emerg Med Australas; 2008 Apr; 20(2):136-43. PubMed ID: 18377403
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Constant morphine infusion for severe sickle cell crisis pain.
    Ives TJ; Guerra MF
    Drug Intell Clin Pharm; 1987; 21(7-8):625-7. PubMed ID: 3608811
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Opioid management and dependency among adult patients with sickle cell disease.
    Feliu MH; Wellington C; Crawford RD; Wood M; Edwards L; Byrd G; Edwards CL
    Hemoglobin; 2011; 35(5-6):485-94. PubMed ID: 21910605
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Emergency department crowding and analgesic delay in pediatric sickle cell pain crises.
    Shenoi R; Ma L; Syblik D; Yusuf S
    Pediatr Emerg Care; 2011 Oct; 27(10):911-7. PubMed ID: 21960091
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changes in platelet count as a predictive tool in sickle cell acute vaso-occlusive crises: a pediatric study.
    Shanley LA; Ebeling M; Titus MO
    Clin Pediatr (Phila); 2011 Jul; 50(7):657-61. PubMed ID: 21382920
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of individualized pain plan on the emergency management of children with sickle cell disease.
    Krishnamurti L; Smith-Packard B; Gupta A; Campbell M; Gunawardena S; Saladino R
    Pediatr Blood Cancer; 2014 Oct; 61(10):1747-53. PubMed ID: 24962217
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
    Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A
    J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vaso-occlusive episodes in older children with sickle cell disease: emergency department management and pain assessment.
    Frei-Jones MJ; Baxter AL; Rogers ZR; Buchanan GR
    J Pediatr; 2008 Feb; 152(2):281-5. PubMed ID: 18206703
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Morphine is associated with acute chest syndrome in children hospitalized with sickle cell disease.
    Birken CS; Khambalia A; Dupuis A; Pastor A; Lee M; Padavattan K; Mekky M; Odame I; Parkin PC
    Hosp Pediatr; 2013 Apr; 3(2):149-55. PubMed ID: 24340416
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Low frequency of meperidine-associated seizures in sickle cell disease.
    Nadvi SZ; Sarnaik S; Ravindranath Y
    Clin Pediatr (Phila); 1999 Aug; 38(8):459-62. PubMed ID: 10456240
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease.
    Gonçalves MS; Queiroz IL; Cardoso SA; Zanetti A; Strapazoni AC; Adorno E; Albuquerque A; Sant'Ana A; dos Reis MG; Barral A; Barral Netto M
    Braz J Med Biol Res; 2001 Oct; 34(10):1309-13. PubMed ID: 11593306
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adjuvant interventions with opioids for vaso-occlusive crisis in sickle cell disease: A mixed treatment network meta-analysis of randomized controlled clinical trials.
    Sridharan K; Sivaramakrishnan G
    J Opioid Manag; 2020; 16(4):267-275. PubMed ID: 32885834
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Twenty-four-hour pattern in emergency department presentation for sickle cell vaso-occlusive pain crisis.
    Auvil-Novak SE; Novak RD; el Sanadi N
    Chronobiol Int; 1996 Dec; 13(6):449-56. PubMed ID: 8974190
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pain management in adult acute sickle cell pain crisis: a viewpoint.
    Udezue E; Herrera E
    West Afr J Med; 2007; 26(3):179-82. PubMed ID: 18399330
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Prospective Emergency Department Quality Improvement Project to Improve the Treatment of Vaso-Occlusive Crisis in Sickle Cell Disease: Lessons Learned.
    Tanabe P; Freiermuth CE; Cline DM; Silva S
    Jt Comm J Qual Patient Saf; 2017 Mar; 43(3):116-126. PubMed ID: 28334590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.